NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
Read More
Tag: metabolic diseases
Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
Chronic liver disease and associated cirrhosis account for one million deaths every year
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
